JP2022525318A5 - - Google Patents

Info

Publication number
JP2022525318A5
JP2022525318A5 JP2021555228A JP2021555228A JP2022525318A5 JP 2022525318 A5 JP2022525318 A5 JP 2022525318A5 JP 2021555228 A JP2021555228 A JP 2021555228A JP 2021555228 A JP2021555228 A JP 2021555228A JP 2022525318 A5 JP2022525318 A5 JP 2022525318A5
Authority
JP
Japan
Prior art keywords
cell
chimeric antigen
amino acid
antigen receptor
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021555228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022525318A (ja
JP7602803B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/020436 external-priority patent/WO2020190483A1/en
Publication of JP2022525318A publication Critical patent/JP2022525318A/ja
Publication of JP2022525318A5 publication Critical patent/JP2022525318A5/ja
Priority to JP2024194375A priority Critical patent/JP2025013530A/ja
Application granted granted Critical
Publication of JP7602803B2 publication Critical patent/JP7602803B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021555228A 2019-03-15 2020-02-28 Cd147キメラ抗原受容体および使用の方法 Active JP7602803B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024194375A JP2025013530A (ja) 2019-03-15 2024-11-06 Cd147キメラ抗原受容体および使用の方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962819403P 2019-03-15 2019-03-15
US62/819,403 2019-03-15
PCT/US2020/020436 WO2020190483A1 (en) 2019-03-15 2020-02-28 Cd147 chimeric antigen receptors and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024194375A Division JP2025013530A (ja) 2019-03-15 2024-11-06 Cd147キメラ抗原受容体および使用の方法

Publications (3)

Publication Number Publication Date
JP2022525318A JP2022525318A (ja) 2022-05-12
JP2022525318A5 true JP2022525318A5 (cg-RX-API-DMAC7.html) 2023-02-24
JP7602803B2 JP7602803B2 (ja) 2024-12-19

Family

ID=72520374

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021555228A Active JP7602803B2 (ja) 2019-03-15 2020-02-28 Cd147キメラ抗原受容体および使用の方法
JP2024194375A Withdrawn JP2025013530A (ja) 2019-03-15 2024-11-06 Cd147キメラ抗原受容体および使用の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024194375A Withdrawn JP2025013530A (ja) 2019-03-15 2024-11-06 Cd147キメラ抗原受容体および使用の方法

Country Status (6)

Country Link
US (1) US12624102B2 (cg-RX-API-DMAC7.html)
EP (1) EP3938402A4 (cg-RX-API-DMAC7.html)
JP (2) JP7602803B2 (cg-RX-API-DMAC7.html)
CN (1) CN113853390B (cg-RX-API-DMAC7.html)
CA (1) CA3132458A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020190483A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240277841A2 (en) * 2020-12-11 2024-08-22 Purdue Research Foundation Human chimeric antigen receptor neutrophils, compositions, kits and methods of use
EP4268991A4 (en) * 2020-12-22 2024-10-30 Araki Technical And Research Co., Ltd. DEVICE FOR PRODUCING A BRANCHING PARTIAL STRUCTURE IN A METAL PIPE AND METHOD FOR PRODUCING A BRANCHING PARTIAL STRUCTURE IN A METAL PIPE
AU2023213691A1 (en) * 2022-01-28 2024-09-05 A2 Biotherapeutics, Inc. Compositions and methods for treating mesothelin positive cancers
WO2024220483A2 (en) * 2023-04-19 2024-10-24 Rutgers, The State University Of New Jersey Grp78 chimeric antigen receptors and combination therapies for treating cancer
CN122206712A (zh) * 2023-11-15 2026-06-12 国立大学法人大阪大学 嵌合抗原受体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7333794A (en) * 1993-08-02 1995-02-28 Houston Biotechnology Incorporated Single-chain immunotoxin compositions and methods for preventing secondary cataracts
WO2010036460A2 (en) 2008-09-29 2010-04-01 Centocor Ortho Biotech Inc. Anti-cd147 antibodies, methods, and uses
EP3250602A1 (en) * 2015-01-26 2017-12-06 Cellectis T cell receptor knock out engineered immune cells, endowed with chimeric antigen receptors binding to cd123 for the treatment of relapsed/refractory acute myeloid lymphoma or blastic plasmacytoid dendritic cell neoplasm
AU2016274989A1 (en) 2015-06-12 2017-11-02 Immunomedics, Inc. Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs
CN107709356A (zh) * 2015-06-26 2018-02-16 南加利福尼亚大学 用于肿瘤特异性活化的掩蔽嵌合抗原受体t细胞
US20200231652A1 (en) * 2015-08-31 2020-07-23 National Research Council Of Canada Tgf-b-receptor ectodomain fusion molecules and uses thereof
JP2020511130A (ja) * 2017-03-09 2020-04-16 サイトメックス セラピューティクス インコーポレイテッド Cd147抗体、活性化可能cd147抗体、ならびにその作製および使用の方法

Similar Documents

Publication Publication Date Title
JP7575100B2 (ja) 免疫細胞活性化のための二重特異性抗体
JP7269167B2 (ja) モジュラー四価二重特異性抗体プラットフォーム
JP2022191241A5 (cg-RX-API-DMAC7.html)
JP2020503015A (ja) 抗cd19のヒト化抗体及びcd19を標的とする免疫エフェクター細胞
JP2022002546A (ja) 細胞
JP2024023228A5 (cg-RX-API-DMAC7.html)
JP2023507729A5 (cg-RX-API-DMAC7.html)
CN109651511B (zh) 一种靶向bcma的嵌合抗原受体及其应用
JP2019513370A5 (cg-RX-API-DMAC7.html)
CA3093008C (en) Monoclonal antibodies that bind to the embryonic stage-specific antigen 4 and their uses
JP2019537433A5 (cg-RX-API-DMAC7.html)
JP2015513920A5 (cg-RX-API-DMAC7.html)
US11945878B2 (en) Switch molecule and switchable chimeric antigen receptor
AU2010299895A1 (en) Anti-CD33 antibodies and use thereof for immunotargeting in treating CD33-associated illnesses
WO2012020622A1 (ja) ヒト型化抗egfr抗体リジン置換可変領域断片及びその利用
JP2022527081A5 (cg-RX-API-DMAC7.html)
JP2020522473A5 (cg-RX-API-DMAC7.html)
JP2020501512A5 (cg-RX-API-DMAC7.html)
JP2021501587A5 (cg-RX-API-DMAC7.html)
JP2021534784A5 (cg-RX-API-DMAC7.html)
CN113683696A (zh) 抗体
JP2022521240A5 (cg-RX-API-DMAC7.html)
WO2022224997A1 (ja) 抗cldn4-抗cd137二重特異性抗体
TW201920272A (zh) 一個需依賴標靶細胞使T細胞接合及活化之不對稱異二聚Fc-ScFv融合抗體形式及其在癌症治療上之應用
US20240400705A1 (en) Composition of recombinant antigen binding molecules and method of making and using thereof